Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology

被引：63

作者：

Shibata, H. ^{[1
]}

Kato, S. ^{[2
,10
]}

Sekine, I. ^{[3
]}

Abe, K. ^{[4
]}

Araki, N. ^{[5
]}

Iguchi, H. ^{[6
]}

Izumi, T. ^{[7
]}

Inaba, Y. ^{[8
]}

Osaka, I. ^{[9
]}

Kato, S. ^{[2
,10
]}

Kawai, A. ^{[11
]}

Kinuya, S. ^{[12
]}

Kodaira, M. ^{[13
]}

Kobayashi, E. ^{[11
]}

Kobayashi, T. ^{[14
]}

Sato, J. ^{[15
]}

Shinohara, N. ^{[16
]}

Takahashi, S. ^{[17
]}

Takamatsu, Y. ^{[18
]}

Takayama, K. ^{[19
,20
]}

Tateishi, U. ^{[21
]}

Nagakura, H. ^{[22
]}

Hosaka, M. ^{[23
]}

Morioka, H. ^{[24
]}

Moriya, T. ^{[25
]}

Yuasa, T. ^{[26
]}

Yurikusa, T. ^{[27
]}

Yomiya, K. ^{[28
]}

Yoshida, M. ^{[29
]}

机构：

[1] Akita Univ, Grad Sch Med, Dept Clin Oncol, Akita, Japan

[2] Juntendo Univ, Dept Clin Oncol, Tokyo, Japan

[3] Univ Tsukuba, Dept Clin Oncol, Tsukuba, Ibaraki, Japan

[4] Chiba Prefectural Univ Hlth Sci, Dept Rehabil, Chiba, Japan

[5] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Orthoped Surg, Osaka, Japan

[6] Natl Hosp Org Shikoku Canc Ctr, Dept Gastroenterol, Matsuyama, Ehime, Japan

[7] Tochigi Canc Ctr, Div Hematol, Utsunomiya, Tochigi, Japan

[8] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi, Japan

[9] Shizuoka Canc Ctr, Div Palliat Med, Sunto Gun, Japan

[10] Iwate Cent Prefectural Hosp, Dept Canc Chemotherapy, Morioka, Iwate, Japan

[11] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo, Japan

[12] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa, Japan

[13] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan

[14] Ishikawa Prefectural Cent Hosp, Dept Diagnost & Intervent Radiol, Kanazawa, Ishikawa, Japan

[15] Iwate Med Univ, Sch Pharm, Dept Clin Pharmaceut, Morioka, Iwate, Japan

[16] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan

[17] Canc Inst Hosp Japanese Fdn Canc Res, Dept Med Oncol, Tokyo, Japan

[18] Fukuoka Univ Hosp, Div Med Oncol Hematol & Infect Dis, Fukuoka, Japan

[19] Seirei Christopher Univ, Hamamatsu, Shizuoka, Japan

[20] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan

[21] Tokyo Med & Dent Univ, Dept Diagnost Radiol & Nucl Med, Tokyo, Japan

[22] KKR Sapporo Med Ctr, Dept Radiol, Sapporo, Hokkaido, Japan

[23] Tohoku Uni, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi, Japan

[24] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan

[25] Kawasaki Med Sch, Department Pathol 2, Kurashiki, Okayama, Japan

[26] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan

[27] Shizuoka Canc Ctr, Div Dent & Oral Surg, Sunto Gun, Japan

[28] Saitama Canc Ctr, Depnt Palliat Care, Kitaadachi Gun, Japan

[29] Int Univ Hlth & Welf, Chemotherapy Res Inst, Dept Hemodialysis & Surg, Ichikawa, Japan

来源：

ESMO OPEN | 2016年 / 1卷 / 02期

关键词：

D O I：

10.1136/esmoopen-2016-000037

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Diagnosis and treatment of bone metastasis requires various types of measures, specialists and caregivers. To provide better diagnosis and treatment, a multidisciplinary team approach is required. The members of this multidisciplinary team include doctors of primary cancers, radiologists, pathologists, orthopaedists, radiotherapists, clinical oncologists, palliative caregivers, rehabilitation doctors, dentists, nurses, pharmacists, physical therapists, occupational therapists, medical social workers, etc. Medical evidence was extracted from published articles describing meta-analyses or randomised controlled trials concerning patients with bone metastases mainly from 2003 to 2013, and a guideline was developed according to the Medical Information Network Distribution Service Handbook for Clinical Practice Guideline Development 2014. Multidisciplinary team meetings are helpful in diagnosis and treatment. Clinical benefits such as physical or psychological palliation obtained using the multidisciplinary team approaches are apparent. We established a guideline describing each specialty field, to improve understanding of the different fields among the specialists, who can further provide appropriate treatment, and to improve patients' outcomes.

引用

页数：11

共 141 条

[81]

Petrylak DP, N ENGL J MED

[82] Impact of zoledronic acid on control of metastatic spinal cord compression [J].

Rades, D. ;

Hakim, S. G. ;

Bajrovic, A. ;

Karstens, J. H. ;

Veninga, T. ;

Rudat, V. ;

Schild, S. E. .

STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (10) :910-916

[83] Matched Pair Analysis Comparing Surgery Followed By Radiotherapy and Radiotherapy Alone for Metastatic Spinal Cord Compression [J].

Rades, Dirk ;

Huttenlocher, Stefan ;

Dunst, Juergen ;

Bajrovic, Amira ;

Karstens, Johann H. ;

Rudat, Volker ;

Schild, Steven E. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) :3597-3604

[84] Goal-Oriented Patient Care - An Alternative Health Outcomes Paradigm [J].

Reuben, David B. ;

Tinetti, Mary E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :777-779

[85] Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan [J].

Ripamonti, C. I. ;

Maniezzo, M. ;

Campa, T. ;

Fagnoni, E. ;

Brunelli, C. ;

Saibene, G. ;

Bareggi, C. ;

Ascani, L. ;

Cislaghi, E. .

ANNALS OF ONCOLOGY, 2009, 20 (01) :137-145

[86] Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05) [J].

Roos, DE ;

Turner, SL ;

O'Brien, PC ;

Smith, JG ;

Spry, NA ;

Burmeister, BH ;

Hoskin, PJ ;

Ball, DL .

RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :54-63

[87]

Roque I, 2011, COCHRANE DATABASE SY

[88] Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion [J].

Rosen, LS ;

Gordon, DH ;

Dugan, W ;

Major, P ;

Eisenberg, PD ;

Provencher, L ;

Kaminski, M ;

Simeone, J ;

Seaman, J ;

Chen, BL ;

Coleman, RE .

CANCER, 2004, 100 (01) :36-43

[89] Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group [J].

Rosen, LS ;

Gordon, D ;

Tchekmedyian, S ;

Yanagihara, R ;

Hirsh, V ;

Krzakowski, M ;

Pawlicki, M ;

de Souza, P ;

Zheng, M ;

Urbanowitz, G ;

Reitsma, D ;

Seaman, JJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3150-3157

[90] Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma - A randomized, double-blind, multicenter, comparative trial [J].

Rosen, LS ;

Gordon, D ;

Kaminski, M ;

Howell, A ;

Belch, A ;

Mackey, J ;

Apffelstaedt, J ;

Hussein, MA ;

Coleman, RE ;

Reitsma, DJ ;

Chen, BL ;

Seaman, JJ .

CANCER, 2003, 98 (08) :1735-1744

← 4 5 6 7 8 9 10 11 12 13 →